Tejnaksh Healthcare Limited passed all four resolutions placed before shareholders at its 19th Annual General Meeting held on September 29, 2026. The company filed the voting results and scrutinizer's report on October 1, 2026, confirming unanimous approval for key agenda items including FY26 financial statements and director re-appointments.

Meeting proceedings and attendance

Ashish Rawandale, Chairman of the Board, presided over the session conducted entirely through video conferencing and other audio-visual means. He welcomed members, directors, key managerial personnel, statutory auditors, and the secretarial auditor. The quorum was ascertained before the meeting was called to order, ensuring compliance with applicable laws and regulator circulars.

The notice convening the meeting and the annual report for FY26 were taken as read with member consent. The Chairman briefed attendees on the company's performance during the fiscal year, highlighting business opportunities and external factors impacting operations.

Voting results and resolution details

Shareholders holding shares as of the cut-off date of September 22, 2026, were eligible to vote. The e-voting window remained open from September 26, 2026, at 9:00 am to September 28, 2026, at 5:00 pm. A total of 31 shareholders attended the meeting through video conferencing, comprising two from the promoter group and 29 public shareholders.

The following table summarizes the voting outcomes for the four resolutions:

For Resolution 1, 2, and 3, the total votes polled were 15,385,657, representing 75.74% of outstanding shares. Promoters voted in favour with 14,967,134 shares, while non-institutional public shareholders cast 418,523 votes in favour.

Resolution 4, concerning material related party transactions, saw promoter group votes excluded due to interest. Only non-institutional public shareholders participated, casting 418,523 votes in favour, which constituted 100% of the valid votes polled for this specific resolution. Two promoters' votes totaling 14,967,134 were marked invalid for this item as they were interested parties.

Director profile: Suhas Vasantrao Thorat

The shareholders approved the re-appointment of Mr. Suhas Vasantrao Thorat (DIN: 09241231) as an Independent Director for a second term of 5 consecutive years. Mr. Thorat, born on December 28, 1966, holds an undergraduate qualification and has more than 15 years of experience as a manager with rich knowledge of supervising and coordinating administration. He possesses diverse knowledge and wide range of experience in the managerial field. Currently, he holds no directorships in other listed companies and has no shareholding in Tejnaksh Healthcare Limited.

Tejnaksh Healthcare has scheduled its 19th Annual General Meeting for September 29, 2026. The virtual meeting will address ordinary business items including the adoption of financial statements for FY26.

The company will also seek shareholder approval for special resolutions concerning board composition and related-party transactions. The meeting will be conducted via Video Conferencing or Other Audio-Visual Means in compliance with Ministry of Corporate Affairs circulars.

Board Appointments

Shareholders will consider the reappointment of Mr. Sanjay Bhikajirao Khatal as a Director. He retires by rotation and offers himself for reappointment. Mr. Khatal holds a B.Tech in Agricultural Engineering and brings 39 years of administrative and technical experience.

Additionally, the Board seeks a special resolution to reappoint Mr. Suhas Vasantrao Thorat as an Independent Director for a second term of five consecutive years. His tenure will run from August 13, 2026, to August 12, 2031. The Nomination and Remuneration Committee recommended his reappointment based on his continued valuable guidance and strong performance.

Related Party Transactions

The AGM agenda includes an ordinary resolution to approve material related-party transactions for the period until the 20th AGM in 2027. The Audit Committee has approved these transactions, noting they are at arm’s length and in the ordinary course of business.

The proposed transactions with Tej Vedaant Healthcare represent 22.81% of the annual consolidated turnover. Transactions involving Dr. Ashish Rawandale and the Tejnaksh Healthcare Foundation each represent 9.27% of the turnover.

Voting Details

Remote e-voting will commence on September 26, 2026, at 9:00 am and conclude on September 28, 2026, at 5:00 pm. The cut-off date for determining eligible members is September 22, 2026. National Securities Depository Limited (NSDL) will facilitate the e-voting process.

M/s. NS Dave & Associates has been appointed as the Scrutinizer to ensure a fair and transparent voting process. Results will be declared within 48 hours of the meeting's conclusion.